Omnicom Group Total Cost of Revenue decreased by 14.9% to $5.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 70.1%, from $3.06B to $5.21B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 8.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.85B | $2.75B | $3.07B | $2.91B | $2.86B | $2.76B | $3.09B | $2.95B | $2.91B | $2.88B | $3.24B | $3.01B | $3.17B | $3.12B | $3.46B | $3.06B | $3.35B | $3.28B | $6.11B | $5.21B |
| QoQ Change | — | -3.5% | +11.7% | -5.3% | -1.6% | -3.6% | +11.9% | -4.3% | -1.5% | -1.2% | +12.9% | -7.3% | +5.5% | -1.6% | +11.0% | -11.6% | +9.4% | -1.9% | +86.2% | -14.9% |
| YoY Change | — | — | — | — | +0.4% | +0.4% | +0.6% | +1.7% | +1.7% | +4.3% | +5.1% | +1.8% | +9.0% | +8.6% | +6.8% | +1.8% | +5.5% | +5.2% | +76.5% | +70.1% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Reportable Segment | $3.06B | $3.26B | $3.24B | $4.45B | $5.17B |
| Total | $3.06B | $3.35B | $3.28B | $6.11B | $5.21B |